Sitbon G, Hurtig M, Palotie A, Lönngren J, Syvänen A C
ProGene Lab AB, Uppsala Science Park, Sweden.
Thromb Haemost. 1997 Apr;77(4):701-3.
We describe a colorimetric screening method for the mutation in codon 506 of the coagulation factor V gene. The nucleotide at the site of the FV:Q506 mutation is identified in an immobilized amplified DNA template by extension of a primer with a hapten-labelled dNTP using a DNA polymerase. The incorporated hapten is detected by an antibody-alkaline phosphatase conjugate that catalyses the formation of a coloured end product. The assay is carried out in a microtiter plate format, and the procedure is identical to that of enzyme immunoassays. It unequivocally identifies the FV:Q506 mutation in heterozygous and homozygous form. The colorimetric minisequencing method gave the same result as a 3H-based minisequencing assay and restriction site analysis with Mn11 used as reference methods. Because of its simple format and numeric result, the novel colorimetric minisequencing method should be an attractive alternative for screening for the FV:Q506 mutation in clinical laboratories.
我们描述了一种用于凝血因子V基因第506密码子突变的比色筛选方法。通过使用DNA聚合酶,利用半抗原标记的dNTP延伸引物,在固定化的扩增DNA模板中鉴定FV:Q506突变位点的核苷酸。通过催化形成有色终产物的抗体-碱性磷酸酶偶联物检测掺入的半抗原。该测定以微量滴定板形式进行,操作程序与酶免疫测定相同。它能明确鉴定杂合子和纯合子形式的FV:Q506突变。比色微测序法与以3H为基础的微测序测定法以及以Mn11用作参考方法的限制性位点分析得出相同结果。由于其简单的形式和数值结果,这种新型比色微测序法对于临床实验室筛选FV:Q506突变应是一种有吸引力的替代方法。